protein
never
mitosi
gene
enzym
regul
transcript
turnov
mrna
protein
cistran
peptidylprolyl
isomeras
contain
aminotermin
domain
tryptophantryptophan
ww
domain
character
two
tryptophan
residu
separ
amino
acid
bind
phosphoryl
serin
threonineprolin
sequenc
substrat
protein
also
isomer
motif
carboxytermin
catalyt
domain
isomer
phosphoryl
serin
threonineprolin
motif
signific
effect
conform
mani
phosphoprotein
conform
switch
catalyz
allow
regul
transcript
factor
mrna
stabil
factor
suscept
grow
list
protein
posttransl
modif
proteas
previous
found
deplet
treatment
calpain
inhibitor
reduc
degrad
induc
nitric
oxid
synthas
ino
murin
aortic
endotheli
cell
maec
stimul
e
coli
endotoxin
lp
ifn
bound
ino
suggest
might
directli
regul
sensit
ino
calpain
may
also
regul
express
inflammatori
protein
effect
calpain
cyclooxygenas
cox
induc
lp
ifn
factor
endotheli
cell
cultur
variou
organ
speci
elev
endotheli
may
contribut
vascular
pathogenesi
enzym
also
signific
endotoxin
action
knockout
mice
resist
lpsinduc
inflamm
death
rel
short
halflif
indic
turnov
may
effect
control
express
ino
degrad
sever
process
calpain
inhibitor
known
suppress
cleavag
ino
purpos
investig
determin
whether
regul
express
induc
lp
ifn
maec
hypothes
would
associ
deplet
would
enhanc
induct
maec
impact
deplet
calpain
activ
also
determin
maec
cultur
aorta
mice
accord
guid
care
use
laboratori
anim
us
nation
institut
health
describ
previous
cell
transduc
short
hairpin
rna
shrna
knockdown
kd
inact
mutant
sequenc
control
select
stabl
modif
produc
kd
maec
approxim
level
protein
found
control
nontransduc
maec
kd
control
maec
incub
dulbecco
minimum
essenti
fetal
bovin
serum
h
treat
medium
lp
ng
ifn
per
ml
agent
variou
time
zvf
ad
h
lpsifn
inhibit
calpain
nineti
cycloheximideml
use
inhibit
protein
synthesi
induct
lpsifn
prostaglandin
product
measur
incub
cell
lpsifn
h
cell
incub
fresh
medium
contain
arachidon
acid
lp
ifn
select
antagonist
without
select
antagonist
medium
collect
h
store
degre
c
prostaglandin
measur
competit
enzymelink
immunosorb
assay
comparison
prostaglandin
standard
manufactur
instruct
rna
extract
trizol
precipit
dissolv
water
cdna
produc
rna
cdna
amplifi
polymeras
chain
reaction
describ
previous
primer
sens
gac
tgg
att
cta
tgg
tg
antisens
aga
ggt
tgg
aga
agg
ct
genbank
access
produc
base
pair
product
half
reaction
electrophores
agaros
gel
imag
analyz
ethidium
bromid
stain
previous
describ
cell
wash
sonic
lysi
buffer
protein
concentr
measur
western
blot
sampl
protein
denatur
separ
trisgylcin
sdspolyacrylamid
gel
transfer
nitrocellulos
immunoprecipit
cell
lysat
protein
incub
antibodi
protein
g
agaros
pulldown
glutathion
stransferas
glutathion
fusion
protein
ad
cell
lysat
protein
glutathionesepharos
sampl
denatur
electrophoresi
western
blot
blot
immunostain
imag
xray
film
enhanc
chemiluminesc
film
scan
digit
imag
protein
analyz
calpain
activ
measur
describ
tompa
et
al
cell
wash
scrape
ml
icecold
pb
collect
centrifug
g
min
collect
cell
resuspend
mm
trishcl
mm
edta
mm
dithiothreitol
mm
benzamidin
mm
phenylmethylsulfonyl
fluorid
mm
sonic
four
time
min
paus
lysat
centrifug
g
min
remov
cell
debri
calpain
activ
measur
fluorogen
calpain
substrat
dimethylamino
phenyl
azo
benzoic
acid
succinimidyl
ester
threonineprolineleucinelysineserineprolineprolineprolineserineprolinearginin
amino
acid
reaction
mixtur
contain
protein
mm
calcium
buffer
mm
hepe
mm
nacl
mm
edta
mm
benzamidin
mm
phenylmethylsulfonyl
fluorid
mm
ph
reaction
start
ad
substrat
initi
veloc
increas
fluoresc
use
nm
excit
nm
emiss
determin
suscept
degrad
exogen
calpain
vitro
also
determin
extract
incub
calpain
reaction
buffer
presenc
porcin
min
reaction
stop
addit
denatur
sampl
buffer
subject
western
blot
describ
cell
wash
three
time
pb
scrape
ml
icecold
pb
cell
collect
centrifug
g
min
pellet
resuspend
reaction
buffer
mm
naacet
mm
edta
mm
dithioerythritol
ph
sonic
four
time
min
break
lysat
centrifug
g
min
remov
debri
reaction
start
mix
cathepsin
substrat
reaction
contain
supernat
protein
describ
werl
et
al
releas
monitor
min
fluoresc
excit
nm
emiss
nm
initi
veloc
determin
band
imag
polymeras
chain
reaction
gel
scan
western
blot
measur
imag
j
nih
prostaglandin
concentr
estim
standard
curv
calpain
activ
indic
fluoresc
increas
per
minut
data
analyz
student
test
analysi
varianc
bonferroni
correct
multipl
comparison
previous
kd
shrna
shown
reduc
compar
control
shrna
maec
protein
low
vehicletr
kd
control
maec
figur
incub
either
lp
ifn
alon
induc
data
shown
howev
stimul
lp
plu
ng
ifn
per
ml
increas
express
protein
appear
increas
earli
h
treatment
induct
persist
h
differ
kd
control
cell
qualit
notic
h
treatment
becam
greater
time
figur
h
signal
protein
increas
control
shrna
maec
figur
signal
significantli
induc
kd
cell
similar
result
obtain
independ
pair
cultur
select
kd
control
shrna
data
shown
prostaglandin
product
increas
kd
maec
control
cell
figur
lpsifn
induc
mrna
kd
control
shrna
cell
indic
rtpcr
messag
increas
within
h
remain
elev
h
howev
differ
kd
control
shrna
maec
time
figur
kd
control
shrna
maec
pretreat
vehicl
calpain
inhibitor
zvf
h
treat
lp
ifn
h
increas
kd
control
cell
figur
control
cell
induc
presenc
zvf
absenc
zvf
also
increas
induct
elev
level
kd
maec
factor
two
figur
pd
select
zvf
calpain
rel
cathepsin
activ
also
increas
induct
kd
control
cell
zvf
increas
induct
mrna
cell
treat
lpsifn
h
figur
effect
deplet
zvf
degrad
assess
cell
induc
lpsifn
treat
cycloheximideml
block
translat
level
protein
fell
initi
valu
h
addit
cycloheximid
control
shrna
cell
figur
howev
similar
decreas
delay
h
kd
maec
protein
fell
initi
h
cycloheximid
zvftreat
control
cell
zvf
also
inhibit
loss
kd
cell
h
confirm
potenti
substrat
calpain
digest
vitro
examin
addit
porcin
extract
lpsifntreat
control
cell
caus
concentrationdepend
loss
signal
figur
sinc
known
bind
substrat
protein
interact
investig
immunoprecipit
extract
vehicl
lpsifntreat
control
cell
produc
detect
western
blot
pull
fusion
protein
glutathionestransferas
shown
given
effect
calpain
inhibitor
calpain
cathepsin
activ
measur
lpsifn
increas
calpain
activ
kd
cell
control
maec
calpain
activ
vehicletr
kd
cell
approxim
activ
control
cell
without
treatment
lpsifn
figur
cathepsin
activ
measur
sinc
zvf
might
also
inhibit
differ
cathepsin
activ
extract
kd
control
maec
without
treatment
lpsifn
figur
regul
level
activ
factor
affect
synthesi
variou
cell
type
suppress
endotheli
cell
increas
induct
product
prostaglandin
lpsifn
figur
despit
nearli
greater
induct
protein
kd
compar
control
maec
differ
induct
mrna
figur
suggest
regul
posttranscript
mechan
consist
posttranscript
effect
deplet
reduc
turnov
figur
sinc
rel
short
halflif
inhibit
turnov
could
lead
larg
cumul
posttranscript
increas
induct
lpsifn
one
prior
studi
reveal
cleavag
reduc
inhibitor
human
synovi
fibroblast
calpain
inhibitor
zvf
increas
induct
figur
reduc
degrad
figur
without
increas
mrna
figur
zvf
also
inhibit
cathepsin
activ
concentr
similar
inhibit
calpain
therefor
pd
select
calpain
compar
cathepsin
test
like
zvf
pd
increas
induct
kd
control
maec
figur
suggest
calpain
respons
restrain
induct
maec
support
idea
shown
first
time
deplet
reduc
calpain
activ
endotheli
cell
contrast
cathepsin
activ
affect
deplet
figur
result
combin
effect
zvf
induct
turnov
suggest
calpain
limit
express
maec
inde
degrad
vitro
indic
potenti
substrat
cell
figur
reduc
calpain
activ
kd
extract
figur
could
due
increas
express
function
calpastatin
unrecogn
endogen
calpain
inhibitor
kd
cell
reduct
express
function
calpain
nevertheless
result
suggest
deplet
reduc
calpain
activ
consequ
reduc
turnov
maec
zvf
reduc
loss
cycloheximidetr
kd
cell
figur
may
due
partial
reduct
calpain
activ
kd
maec
figur
partial
reduc
calpain
activ
could
account
intermedi
loss
cycloheximidetr
kd
cell
allow
zvf
suppress
turnov
may
also
explain
abil
calpain
inhibitor
increas
induct
kd
control
maec
figur
partial
reduct
calpain
activ
may
due
incomplet
suppress
shrna
may
also
function
modul
calpain
activ
absolut
requir
previous
observ
deplet
zvf
increas
induct
ino
reduc
degrad
physic
interact
ino
ww
catalyt
domain
appear
contribut
associ
suggest
deplet
might
alter
suscept
target
digest
calpain
exampl
could
associ
substrat
catalyz
prolin
isomer
affect
proteas
sensit
contrast
ino
howev
interact
detect
role
direct
interact
complet
exclud
howev
sinc
associ
prolin
isomeras
put
substrat
may
weak
transient
could
also
affect
associ
ino
protein
may
indirectli
regul
proteolysi
thu
effect
calpain
activ
andor
associ
factor
could
affect
sensit
digest
calpain
overal
result
indic
regul
induct
ino
previous
unknown
effect
calpainmedi
turnov
maec
mechan
regul
calpain
activ
investig
particular
could
affect
express
activ
calpain
subunit
endogen
inhibitor
heterodimer
calpain
calpastatin
effect
acut
chronic
inflammatori
respons
vasculatur
complic
multipl
primari
secondari
stimuli
may
present
cellular
factor
suppli
arachidon
acid
complement
variou
prostaglandin
synthas
express
prostaglandin
receptor
deplet
inhibit
calpain
caus
overinduct
ino
consequ
coinduct
two
particular
enzym
may
signific
peroxynitrit
increas
prostaglandin
synthesi
snitrosyl
activ
enzym
contribut
cell
injuri
impact
coinduct
ino
endothelium
requir
investig
role
calpain
activ
may
also
complex
wellstudi
calpain
heterodimer
mcalpain
cleav
numer
protein
substrat
enhanc
downregul
differ
signal
transduct
process
excess
calpain
activ
also
caus
cell
injuri
death
sever
organ
reduc
calpain
inhibitor
thu
remain
determin
whether
specif
calpain
endotheli
cell
exploit
manipul
inflammatori
activ
therapeut
use
manner
case
result
indic
degrad
calpain
regul
express
via
effect
calpain
activ
maec
deplet
increas
induct
lpsifn
posttranscript
mechan
associ
reduc
calpain
activ
consist
short
lifespan
maec
suppress
calpain
inhibitor
increas
induct
previous
unknown
connect
suggest
may
normal
function
maintain
calpain
activ
consequ
restrain
induct
ino
perhap
substrat
maec
like
regul
rang
calpaindepend
endotheli
activ
cox
cyclooxygenas
lp
e
coli
endotoxin
ino
induc
nitric
oxid
synthas
ifn
kd
knockdown
maec
murin
aortic
endotheli
cell
protein
never
mitosi
gene
shrna
short
hairpin
rna
zvf
carbobenzoxyvalinylphenylalanin
author
declar
compet
interest
tl
dgh
design
studi
collect
result
ra
ril
aid
cell
cultur
puromycin
select
western
blot
vs
yh
lk
respons
product
lentivirus
tl
dgh
main
author
tl
ra
vs
yh
lk
dgh
edit
manuscript
author
read
approv
final
manuscript
